Developing precision BioGene therapeutics designed to overcome treatment resistance and improve outcomes for patients with difficult-to-treat cancers
EPIGENOMAX THERAPEUTICS LLC
Transforming Cancer Treatment by Addressing One of Oncology's Greatest Challenges
EpigenoMax Therapeutics is advancing a new generation of precision oncology solutions that combine molecular diagnostics with targeted BioGene therapeutics to identify, attack and eliminate cancer with greater precision.
EpigenoMax Therapeutics LLC
We are transforming bio-genes into precision targeting therapeutics for malignancies
- Overcoming treatment barriers by PCSS;
- Developing integrated solution to clinical oncology by PCDPCSS;
- Paving the way in the fight against malignancies by innovative Bio-gene therapeutics
Innovative Cancer Solutions
EpigenoMax aims to integrate sensitive molecular fluorescent diagnostics with customized biological gene therapies to deliver patients with a seamless and highly effective treatment experience
Precision Molecular Diagnosis
Employing advanced diagnostic technologies to detect cancer at the molecular level for informed treatment decision-making in Programmable Cellular Surgery
Programmable Cellular Surgery
Providing customized therapeutics using the PCS Kit, a lentiviral-based biological gene therapy designed for high specificity and effective elimination of cancer cells
Leading the future with PMDPCS's cutting-edge solutions
Leveraging PMDPCS for seamless transaction of cancer precision diagnosis and customized treatment
Patient-Centered Care
EpigenoMax Therapeutics is dedicated to advancing scientific excellence and delivering clinical value—innovating transformative solutions to offer hope to cancer patients.
Get in touch
Telephone: +12039078908
E-mail: xianyong.ma@epigenomax.com
Address: 101 College St, New Haven, 06510-2407, Connecticut, United States